Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Glioma 1Glioblastoma 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Rituximab 13Cyclophosphamide 12Vincristine 11Prednisone 11Doxorubicin 8Radiotherapy 6Immunohistochemistry 5VAP-cyclo protocol 4Peripheral Blood Stem Cell Transplantation 4Gene Expression Profiling 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tositumomab I-131 3Polymerase Chain Reaction 3Microarray Analysis 3Methotrexate 3Cytarabine 3Melphalan 2Interferon-alpha 2Filgrastim 2Carmustine 2Bortezomib 2Bendamustine Hydrochloride 2thymoglobulin 1sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Follicular × carmustine, poliferprosan 20 drug combination × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡